|
Symbol
|
LVBVLK | XRYLTQ | IHTEFG | LCDQLK | LTHCLK | OOJRCH | AAIDTQ | 1016BC | POMRCH | PRZRCH | PWCRCH | RMAA0V | RMBX0V | RMATBV | RMAZDV | LZMRCH | LZORCH | RMBJ7V | MAIRCH | RCDRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | LUKB Autocallable Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | LUKB Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | Multi Vonti | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible |
|
Basiswert
|
Nestlé S.A. / Swatch Group I / Swiss Life Hldg. N / Swiss RE AG | Compagnie Financière Richemont SA / Novartis Sandoz Basket / Roche PS / Swatch Group I / Swiss RE AG | Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG | Barry Callebaut AG / Nestlé S.A. / Roche PS / Swiss RE AG / UBS Group AG | Swiss Life / Swiss Re / Zurich | Nestlé S.A. / Sika AG / Swiss RE AG | Swiss Re / UBS / Zurich | Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Kühne & Nagel Intl. AG / Logitech International SA / Lonza Group N / Swiss RE AG / UBS Group AG | Swiss Life Hldg. N / Swiss RE AG / Zurich Insurance Group AG / Helvetia Baloise Holding AG | Schindler PS / Swiss RE AG / Swisscom N | Companie Financière Richemont SA / Geberit AG / Swiss RE AG | Nestlé S.A. / Partners Group Hldg. AG / Swiss RE AG | Holcim AG / Swiss RE AG / Lonza Group N | Swiss Life Hldg. N / Swiss RE AG / Helvetia Baloise Holding AG | Sika AG / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Swiss Life / Swiss Re / Zurich | Novartis AG / Roche PS / Swiss Life Hldg. N / Swiss RE AG / Zurich Insurance Group AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
20.07.2026 | 22.09.2028 | 28.06.2029 | 03.06.2026 | 09.07.2027 | 15.07.2026 | 19.07.2027 | 06.11.2026 | 31.07.2026 | 24.02.2027 | 27.06.2029 | 26.04.2027 | 31.05.2027 | 25.06.2026 | 09.07.2026 | 31.07.2026 | 07.08.2029 | 19.08.2027 | 24.09.2027 | 26.09.2028 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
172.51 | 160.62 | 176.28 | 824.8414 | 58.7776 | 997.10 | 265.045 | 158.665 | 103.5375 | 416.78 | 364.13 | 113.44 | 103.04 | 407.30 | 791.945 | 422.25 | 110.5875 | 142.30 | 103.9125 | 97.685 |
|
Maximal- rendite p.a. |
25.86% | 10.32% | - | 15.11% | 6.15% | 14.52% | 1.96% | 24.48% | 3.42% | 7.52% | 7.75% | 8.57% | 5.90% | 4.70% | 13.43% | 8.41% | 5.85% | 13.75% | 5.91% | 5.28% |
| Geld | - | 87.16 | 88.21 | - | - | 97.24 | 101.09 | 94.64 | 100.56 | 97.08 | 90.92 | - | 97.70 | - | - | 98.36 | 96.20 | - | 98.28 | 99.00 |
| Brief | - | 87.96 | - | - | - | 98.04 | 101.90 | 95.39 | 101.37 | 97.88 | 91.72 | - | - | - | - | 99.16 | 97.00 | - | 99.08 | 99.80 |